The protective mechanism of anisodamine on liver ischemia-reperfusion injury in rats
Ping Wang
Abstract
Ping Wang
Abstract
Objective To study the protective mechanism of anisodamine on liver ischemia-reperfusion injury in rats.Methods One hundreds and sixty male Wistar rats were randomly divided into the normal control group (n=10), ischemia-reperfusion group (n=50), physiologic saline group (n=50)and anisodamine group (n=50). The animals were killed at 1st,3rd, 6th,12th,24th h after ischemia induced for 60 min and followed by reperfusion. Plasma and(or) liver endothelin-1 (ET-1), hyaluronic acid (HA), glutamic-pyruvic transaminase enzyme (ALT) and malondialdehyde (MDA) were measured. Liver intracellular i and adenosine triphosphate (ATP) after being reperfused for 1 h were measured. Meanwhile, the histopathologic hepatic alterations were also observed.Results Plasma ET-1, HA, ALT and liver ET-1, MDA, intracellular i concentrations were markedly increased and liver ATP markedly decreased after liver ischemia-reperfusion. It was found that an intravenous injection of anisodamine (2.0 mg/kg) before ischemia-reperfusion could significantly decrease the levels of HA, ALT, MDA, intracellular i and increase ATP concentrations in plasma and(or) liver. Meanwhile, the histopathologic hepatic alterations were significantly lessened.Conclusions The anisodamine have protective effects on liver ischemia-reperfusion injury.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the protective mechanism of anisodamine on liver ischemia-reperfusion injury in rats.Methods One hundreds and sixty male Wistar rats were randomly divided into the normal control group (n=10), ischemia-reperfusion group (n=50), physiologic saline group (n=50)and anisodamine group (n=50). The animals were killed at 1st,3rd, 6th,12th,24th h after ischemia induced for 60 min and followed by reperfusion. Plasma and(or) liver endothelin-1 (ET-1), hyaluronic acid (HA), glutamic-pyruvic transaminase enzyme (ALT) and malondialdehyde (MDA) were measured. Liver intracellular i and adenosine triphosphate (ATP) after being reperfused for 1 h were measured. Meanwhile, the histopathologic hepatic alterations were also observed.Results Plasma ET-1, HA, ALT and liver ET-1, MDA, intracellular i concentrations were markedly increased and liver ATP markedly decreased after liver ischemia-reperfusion. It was found that an intravenous injection of anisodamine (2.0 mg/kg) before ischemia-reperfusion could significantly decrease the levels of HA, ALT, MDA, intracellular i and increase ATP concentrations in plasma and(or) liver. Meanwhile, the histopathologic hepatic alterations were significantly lessened.Conclusions The anisodamine have protective effects on liver ischemia-reperfusion injury.
Key concepts: Anisodamine, Ischemia, Malondialdehyde, Reperfusion injury, Medicine, Intracellular, Internal medicine, Endocrinology